x Dear All, We are currently updating our user ranking and ratings, kindly bear with us, we will be back to normal shortly.. Thank you - MoneyVidya.com team
 
Search for:
Advanced Search
Up ShareSep Up
BtnMakeaTip
PostBlog
 
Free
 
You are in:

Home

»

Research

»

Stocks

»

Pharma and Healthcare

»

Large

Wockhardt Rs. 150.90 BigDownArrow0.9 (0.59%)

Charts & Data
Hello, you either have JavaScript turned off or an old version of Macromedia's Flash Player. Get The Latest Flash Player.
  • Latest Price
  • 150.90
  • Open Price
  • 150.00
  • Previous Close
  • 151.80
  • Change
  • DownArrow0.9(0.59%)
  • Volume
  • 32,601
  • Daily High
  • 153.40
  • Daily Low
  • 150.00
  • 52 Week High
  • 205.75
  • 52 Week Low
  • 66.50
  • Market Cap
  • 1,651.39 Cr.
Related Stocks..
Stock Picks
See All (5)
  •  
  • marcford says, BUY Wockhardt.
    For 6 Months | Completed on Jan 04th, 2010 03:55 PM | Created Jul 03rd, 2009 12:00 AM
  •  
  • joshipramod says, BUY Wockhardt.
    For 1 Week | Completed on Jun 02nd, 2009 02:35 PM | Created May 26th, 2009 12:00 AM
  •  
  • SubuJr says, BUY Wockhardt.
    For 3 Days | Completed on May 21st, 2009 02:15 PM | Created May 21st, 2009 01:09 PM
  •  
  • truegenius says, BUY Wockhardt.
    For Intraday | Completed on Mar 09th, 2009 03:55 PM | Created Mar 09th, 2009 09:06 AM
News & Blogs
See All (122)
Secured lenders are with us: Wockhardt
Source - Yahoo Finance - 8 days ago
Wockhardt Ltd, the Mumbai-based company which is battling petitioners seeking approval for sale of its business to Abbott Labs, said the CDR lender... (more)
QVT proposes new recast plan to Wockhardt
Source - Business Standard - 17 days ago
The US-based investor fund QVT has proposed an alternative debt restructuring plan to Wockhardt Ltd. QVT and a group of aggrieved investors had fil... (more)
US fund QVT moots new rejig plan for Wockhardt FCCBs
Source - Businessline Corporate - 17 days ago
Even as drug-maker Wockhardt fights wind-up petitions against it in the Bombay High Court, QVT Advisors Private Ltd has said that it supports an FC... (more)
Wockhardt Hospital plans Rs 400 crore expansion
Source - Business Standard - 28 days ago
As part of its expansion plans, Wockhardt Hospitals Ltd (WHL) is planning to open 4 new super speciality hospitals in the next three years and inve... (more)
Wockhardt cuts loss by half
Source - Business Standard - about 1 month ago
Troubled drug major Wockhardt posted a net loss of Rs 181.2 crore for its fourth quarter ended December 31, 2009, which is almost half the net loss... (more)
Wockhardt narrows Q4 loss to Rs 181 cr
Source - The Economic Times - about 1 month ago
Drug firm Wockhardt Ltd on Monday said the group narrowed its consolidated net loss to Rs 181.23 crore in the fourth quarter ended December 31, 200... (more)
Wockhardt narrows Q4 loss to Rs 181 cr
Source - The Economic Times - about 1 month ago
Drug firm Wockhardt Ltd on Monday said the group narrowed its consolidated net loss to Rs 181.23 crore in the fourth quarter ended December 31, 200... (more)
Wockhardt debt restructure sees informal progress
Source - Business Standard - about 1 month ago
Indian banks may opt for FCCB conversion into preference shares. (more)
QVT threatens to block nutrition biz sale
Source - Business Standard - about 1 month ago
The US-based investor fund QVT Advisors today threatened to block debt-ridden Wockhardts Rs 620-crore sale of nutrition business to Abott, intensif... (more)
Wockhardt-Abbot deal gets high court go-ahead
Source - Business Standard - about 1 month ago
Wockhardts efforts to restructure its operations have received a boost with the Bombay High Court declining to grant an injunction sought by a sect... (more)
Related
You might be interested in this stock:
Dishman Pharmaceuticals & Chemicals
213.0UP0.6(0.3%)
 
 
Related pick:
SKJ
Currently (2.00)/5 Stars.
said
BUY Aurobindo Pharma and sell it in 1 year
4 days ago | 0 comments
 
 
 
  • Got Feedback?
    Help us make MoneyVidya better!
    Learn More
  • Did you know?
    Our rating system identifies top performers
    Learn More
  • Whats New!
    Right now, everything :-)
    Learn More
  • Like MoneyVidya?
    Help us spread the word.
    Learn More
  • Are you an Analyst?
    Partner with MoneyVidya.
    Learn More
MoneyVidya © 2008. Use of this site is subject to express Terms & Conditions, Code of Conduct, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by on MoneyVidya.com should not be construed as research, trading picks or recommendations, or investment advice and is provided with no warrants as to its accuracy. All stock market data, including stock symbols, stock quotes, share prices, and other fundamental data is provided by Tickerplant infovending Pvt. Ltd. Stock market quotes are delayed by at least 15 minutes for the NSE and BSE. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by MoneyVidya.com.